Local regulation of immune responses: Corneal endothelial cells alter T cell activation and cytokine production

Cytokine

Volumn 12, Issue 3, 2000, Pages 253-264

  Mi, Pei ^a   Gregerson, Dale S ^a   Kawashima, Hidetoshi ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Calcium; Cellular activation; Cytokines; Signal transduction; T lymphocytes

Indexed keywords

CALCIUM ION; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; IONOMYCIN; T LYMPHOCYTE RECEPTOR; THAPSIGARGIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL CLONE; CELL CULTURE; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CYTOKINE RELEASE; EMBRYO; ENDOTHELIUM CELL; HYBRIDOMA; IMMUNE RESPONSE; IMMUNOREGULATION; LEUKEMIA CELL LINE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0033947827     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1999.0542     Document Type: Article

References (47)

1. Medawar P. Immunity to homologous grafted skin: III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol. 29:1948;58-69.
2. Streilein JW, Ksander BR, Taylor AW. Immune deviation in relation to ocular immune privilege. J Immunol. 158:1997;3557-3560.
3. Streilein JW. Immune privilege as the result of local tissue barriers and immunosuppressive microenvironments. Curr Opin Immunol. 5:1993;428-432.
4. Granstein RD, Staszewski R, Knisely TL, Zeira E, Nazareno R, Latina M, Albert DM. Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. J Immunol. 144:1990;3021-3027.
5. Taylor AW, Streilein JW, Cousins SW. Identification of alpha-melanocyte stimulating hormone as a potential immunosuppressive factor in aqueous humor. Curr Eye Res. 11:1992;1199-1206.
6. Taylor AW, Streilein JW, Cousins SW. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppressive activity of normal aqueous humor. J Immunol. 153:1994;1080-1086.
7. Ferguson TA, Fletcher S, Herndon J, Griffiths TS. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol. 155:1995;1746-1756.
8. Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA. Fas ligand-induced apoptosis as a mechanism of immune privilege [see comments]. Science. 270:1995;1189-1192.
9. Kawashima H, Yamagami S, Tsuru T, Gregerson DS. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation. Eur J Immunol. 27:1997;2490-2494.
10. Yamagami S, Kawashima H, Tsuru T, Yamagami H, Kayagaki N, Yagita H, Okumura K, Gregerson DS. Role of Fas-Fas ligand interactions in the immunorejection of allogenic mouse corneal transplants. Transplantation. 64:1997;1107-1111.
11. Caspi RR, Roberge FG. Glial cells as suppressor cells: characterization of the inhibitory function. J Autoimmun. 2:1989;709-722.
12. Liversidge J, McKay D, Mullen G, Forrester JV. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retinal barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol. 149:1993;315-330.
13. Helbig H, Gurley RC, Palestine AG, Nussenblatt RB, Caspi RR. Dual effect of ciliary body cells on T lymphocyte proliferation. Eur J Immunol. 20:1990;2457-2463.
14. Foets B, Oord J, Billiau A, Damme J, Missotten L. Heterogeneous induction of major histocompatibility complex class II antigens on corneal endothelium by interferon-γ Invest Ophthalmol Vis Sci. 32:1991;341-345.
15. Obritsch WF, Kawashima H, Evangelista A, Ketcham JM, Holland EJ, Gregerson DS. Inhibition of in vitro T cell activation by corneal endothelial cells. Cell Immunol. 144:1992;80-94.
16. Kawashima H, Gregerson DS. Corneal endothelial cells block T cell proliferation, but not T cell activation or responsiveness to exogenous IL-2. Curr Eye Res. 13:1994;575-585.
17. Kawashima H, Prasad SA, Gregerson DS. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J Immunol. 153:1994;1982-1989.
18. Ruiz-Ruiz MC, Oliver FJ, Izquierdo M, Lopez-Rivas A. Activation-induced apoptosis in Jurkat cells through a myc-independent mechanism. Mol Immunol. 32:1995;947-955.
19. Morford LA, Elliott LH, Carlson SL, Brooks WH, Roszman TL. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol. 159:1997;4415-4425.
20. Kawashima H, Gregerson DS. Corneal endothelial cells create and maintain a unique microenvironment for immune cells. Reg Immunol. 6:1994;134-137.
21. Shaw JP, Crabtree GR. Identification of a putative regulator of early T cell activation genes. Science. 241:1988;202-205.
22. Kubo M, Kincaid RL, Ransom JT. Activation of the interleukin-4 gene is controlled by the unique calcineurin-dependent transcriptional factor NF(P). J Biol Chem. 269:1994;19441-19446.
23. Rooney JW, Hoey T, Glimcher LH. Coordinate and cooperative roles for NF-AT and AP-1 in the regulation of the murine IL-4 gene. Immunity. 2:1995;473-483.
24. Lee HJ, Matsuda I, Naito Y, Yokota T, Arai N, Arai K. Signals and nuclear factors that regulate the expression of interleukin-4 and interleukin-5 genes in helper T cells. J Aller Clin Immunol. 94:1994;594-604.
25. Mori A, Suko M, Nishizaki Y, Kaminuma O, Kobayashi S, Matsuzaki G, Yamamoto K, Ito K, Tsuruoka N, Okudaira H. IL-5 production by CD4+ T cells of asthmatic patients is suppressed by glucocorticoids and the immunosuppressants FK506 and cyclosporin A. Int Immunol. 7:1995;449-457.
26. Paliogianni F, Boumpas DT. Prostaglandin E2 inhibits the nuclear transcription of the human interleukin 2, but not the Il-4, gene in human T cells by targeting transcription factors AP-1 and NF-AT. Cell Immunol. 171:1996;95-101.
27. Sloan-Lancaster J, Evavold BD, Allen PM. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature. 363:1993;156-159.
28. Sloan-Lancaster J, Shaw AS, Rothbard JB, Allen PM. Partial T cell signalling: altered phospho-zeta and lack of zap70 recruitment in APL-induced T cell anergy. Cell. 79:1994;913-922.
29. Sloan-Lancaster J, Steinberg TH, Allen PM. Selective activation of the calcium signaling pathway by altered peptide ligands. J Exp Med. 184:1996;1525-1530.
30. Ahuja SS, Paliogianni F, Yamada H, Balow JE, Boumpas DT. Effect of transforming growth factor-beta on early and late activation events in human T cells. J Immunol. 150:1993;3109-3118.
31. Brabletz T, Pfeuffer I, Schorr E, Siebelt F, Wirth T, Serfling E. Transforming growth factor beta and cyclosporin A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site. Mol Cell Biol. 13:1993;1155-1162.
32. Roszman TL, Brooks WH, Elliott LH. Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factor. J Neurosurg. 67:1987;874-879.
33. Elliott LH, Brooks WH, Roszman TL. Suppression of high affinity IL-2 receptors on mitogen activated lymphocytes by glioma-derived suppressor factor. J Neuro-Oncol. 14:1992;1-7.
34. Elliott LH, Brooks WH, Roszman TL. Inability of mitogen-activated lymphocytes obtained from patients with malignant primary intracranial tumors to express high affinity interleukin 2 receptors. J Clin Invest. 86:1990;80-86.
35. Roszman T, Elliott L, Brooks W. Modulation of T-cell function by gliomas. Immunol Today. 12:1991;370-374.
36. Kiefer R, Supler ML, Toyka KV, Streit WJ. In situ detection of transforming growth factor-beta mRNA in experimental rat glioma and reactive glial cells. Neurosci Lett. 166:1994;161-164.
37. Roberge FG, Caspi RR, Chan CC, Nussenblatt RB. Inhibition of T lymphocyte proliferation by retinal glial Muller cells: reversal of inhibition by glucocorticoids. J Autoimmun. 4:1991;307-314.
38. Roberge FG, Caspi RR, Nussenblatt RB. Glial retinal Muller cells produce IL-1 activity and have a dual effect on autoimmune T helper lymphocytes. Antigen presentation manifested after removal of suppressive activity. J Immunol. 140:1988;2193-2196.
39. Caspi RR, Roberge FG, Nussenblatt RB. Organ-resident, nonlymphoid cells suppress proliferation of autoimmune T-helper lymphocytes. Science. 237:1987;1029-1032.
40. Helbig H, Kittredge K, Coca-Prados M, Davis J, Palestine A, Nussenblatt R. Mammalian ciliary-body epithelial cells in culture produce transforming growth factor-beta. Graefe's Arch Clin Exp Ophthalmol. 229:1991;84-87.
41. Caspi R. A rapid one-step multiwell tray test for release of soluble mediators. J Immunol Methods. 93:1986;141-144.
42. Karttunen J, Shastri N. Measurement of ligand-induced activation in single viable T cells using the lacZ reporter gene. Proc Natl Acad Sci U S A. 88:1991;3972-3976.
43. Fiering S, Northrop JP, Nolan GP, Mattila PS, Crabtree GR, Herzenberg LA. Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. Gene Dev. 4:1990;1823-1834.
44. Mueller DL, Chiodetti L, Bacon PA, Schwartz RH. Clonal anergy blocks the response to IL-4, as well as the production of IL-2, in dual-producing T helper cell clones. J Immunol. 147:1991;4118-4125.
45. Mueller DL, Chen ZM, Schwartz RH, Gorman DM, Kennedy MK. Subset of CD4+ T cell clones expressing IL-3 receptor alpha-chains uses IL-3 as a cofactor in autocrine growth. J Immunol. 153:1994;3014-3027.
46. Deeths MJ, Mescher MF. B7-1-dependent co-stimulation results in qualitatively and quantitatively different responses by CD4+ and CD8+ T cells. Eur J Immunol. 27:1997;598-608.
47. Nolan GP, Fiering S, Nicholas JF, Herzenberg LA. Fluorescence-activated cell analysis and sorting of viable mammalian cells based on beta-D-galactosidase activity after transduction of Escherichia coli lacZ. Proc Natl Acad Sci U S A. 85:1988;2603-2607.